CYBERDYNE Inc. (TYO:7779)
186.00
+1.00 (0.54%)
Jul 25, 2025, 3:30 PM JST
CYBERDYNE Revenue
In the fiscal year ending March 31, 2025, CYBERDYNE had annual revenue of 4.38B JPY with 0.69% growth. CYBERDYNE had revenue of 1.22B in the quarter ending March 31, 2025, with 7.05% growth.
Revenue
4.38B
Revenue Growth
+0.69%
P/S Ratio
8.96
Revenue / Employee
20.78M
Employees
211
Market Cap
39.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 4.38B | 30.00M | 0.69% |
Mar 31, 2024 | 4.35B | 1.07B | 32.38% |
Mar 31, 2023 | 3.29B | 1.14B | 52.98% |
Mar 31, 2022 | 2.15B | 275.00M | 14.67% |
Mar 31, 2021 | 1.88B | 83.00M | 4.63% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 866.03B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |